BrainPatch
PrivateLast Round
Seed
Oct 8, 2026
Est. Valuation
$10.5M
Total Funding Raised
$2.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BrainPatch operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was an Accelerator round in June 2026.
BrainPatch is a neurotechnology company that develops AI-powered, non-invasive brain stimulation devices designed to enhance mental well-being, provide stress relief, and improve cognitive performance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Consumer Electronics
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainPatch Comparables
Compare BrainPatch with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensate | 86% | |
| Parasym | 84% | |
| Sens.ai Incorporated | 83% |
For institutional investors. Book with your work email.
BrainPatch Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 8, 2026 | ||||
| Accelerator | Jun 1, 2026 | ||||
| Seed | Aug 18, 2025 | ||||
| Pre Seed | Jul 17, 2024 | ||||
| Pre Seed | Oct 8, 2021 | ||||
Seed | Sep 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrainPatch Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Basck Limited | Pre Seed |
| StartX | Accelerator |
| European Commission | Grant |
| Innovate UK | Grant |
| Innovate UK | Grant |
| Big Sky Capital | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2026
Completed a seed funding round.
- Aug 20, 2026
Monthly visitors grew 153% MoM, reaching 5.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 8, 2026
BrainPatch Ltd. is represented at BioTechX Europe in Switzerland by its Chief Science Officer, Dr Sergii Tukaiev, and builds new connections with researchers and industry leaders.
For institutional investors. Book with your work email.
BrainPatch Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainPatch's valuation, stock price, and market status.
Is BrainPatch a public or private company?
BrainPatch is a private company.
What is the current stock price of BrainPatch?
BrainPatch is a private company, so its shares have no public market price. Caplight tracks BrainPatch's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainPatch worth (valuation)?
BrainPatch's valuation is estimated at $10.5M based on funding round data.
Can I buy BrainPatch stock?
BrainPatch shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainPatch's last funding round?
BrainPatch's most recent funding round was Seed on October 8, 2026.
Who are the main investors in BrainPatch?
Key investors in BrainPatch include D&FG Elements, Neuromotion Ventures.
Will BrainPatch IPO soon?
No public IPO plans have been announced for BrainPatch.
How can I track BrainPatch secondary market activity?
Caplight tracks bids, offers, and trades in BrainPatch's shares on secondary markets.